Cellectis S.A. - American Depositary Shares, each representing 1 Ordinary Shares (CLLS)

32 filings reported holding CLLS - Cellectis S.A. - American Depositary Shares, each representing 1 Ordinary Shares as of Q3 2024.
Cellectis S.A. - American Depositary Shares, each representing 1 Ordinary Shares (CLLS) has 27 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 9.77M shares of 100M outstanding shares and own 9.73% of the company stock.
Largest 10 shareholders include Long Focus Capital Management, LLC (4.62M shares), Capital International Investors (1.85M shares), UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC (1.44M shares), BAILLIE GIFFORD & CO (694K shares), PRINCIPAL FINANCIAL GROUP INC (412K shares), MACQUARIE GROUP LTD (227K shares), KBC Group NV (163K shares), LPL Financial LLC (92.4K shares), MORGAN STANLEY (91.5K shares), and TWO SIGMA INVESTMENTS, LP (33.4K shares).
This table shows the top 27 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.